<!DOCTYPE html>
<html lang="it">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Infografica 3 â€” Confined Placental Mosaicism</title>
<link href="https://fonts.googleapis.com/css2?family=Fraunces:ital,wght@0,300;0,700;1,400&family=Space+Grotesk:wght@400;500;700&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
<style>
  :root {
    --cream: #faf6ef;
    --teal: #1a6b6b;
    --teal2: #124e4e;
    --teal-light: #e0f0f0;
    --gold: #c8881a;
    --red: #c0392b;
    --red-light: #fdeae8;
    --sage: #5d8b6e;
    --ink: #1e2832;
    --muted: #7a8694;
    --border: rgba(26,107,107,0.18);
  }
  * { margin:0; padding:0; box-sizing:border-box; }
  body {
    background: var(--cream);
    color: var(--ink);
    font-family: 'Space Grotesk', sans-serif;
    min-height: 100vh;
    overflow-x: hidden;
  }

  /* HEADER */
  .header {
    background: var(--teal2);
    padding: 48px 64px 42px;
    position: relative;
    overflow: hidden;
  }
  .header::before {
    content:'';
    position:absolute; bottom:-80px; right:-60px;
    width:360px; height:360px;
    border: 60px solid rgba(255,255,255,0.05);
    border-radius: 50%;
  }
  .header::after {
    content:'';
    position:absolute; bottom:10px; right:120px;
    width:160px; height:160px;
    border: 30px solid rgba(255,255,255,0.04);
    border-radius: 50%;
  }
  .eyebrow {
    font-family: 'JetBrains Mono', monospace;
    font-size: 11px;
    letter-spacing: 3px;
    color: rgba(200,136,26,0.9);
    text-transform: uppercase;
    margin-bottom: 18px;
  }
  .header h1 {
    font-family: 'Fraunces', serif;
    font-weight: 700;
    font-size: clamp(30px, 4.5vw, 56px);
    color: #f0ede5;
    line-height: 1.1;
    max-width: 680px;
  }
  .header h1 em { color: var(--gold); font-style: italic; }
  .header-sub {
    margin-top: 16px;
    color: rgba(240,237,229,0.6);
    font-size: 14px;
    line-height: 1.7;
    max-width: 580px;
  }
  .source {
    margin-top: 22px;
    font-family: 'JetBrains Mono', monospace;
    font-size: 10px;
    color: rgba(240,237,229,0.35);
    letter-spacing: 1.5px;
  }

  /* MAIN */
  .main { padding: 44px 64px; }

  /* DEFINITION ROW */
  .def-row {
    display: grid;
    grid-template-columns: 3fr 2fr;
    gap: 28px;
    margin-bottom: 36px;
    animation: fadeIn 0.6s ease both;
  }
  .def-card {
    background: white;
    border-radius: 16px;
    padding: 32px;
    border: 1.5px solid var(--border);
    box-shadow: 0 4px 20px rgba(0,0,0,0.05);
  }
  .def-card h3 {
    font-family: 'Fraunces', serif;
    font-size: 20px;
    color: var(--teal);
    margin-bottom: 14px;
  }
  .def-card p { font-size: 14px; line-height: 1.8; color: var(--ink); }

  .big-stat-card {
    background: var(--teal);
    border-radius: 16px;
    padding: 32px;
    color: white;
    display: flex;
    flex-direction: column;
    justify-content: center;
    align-items: center;
    text-align: center;
  }
  .bsc-label {
    font-family: 'JetBrains Mono', monospace;
    font-size: 10px;
    letter-spacing: 2px;
    color: rgba(255,255,255,0.6);
    margin-bottom: 12px;
    text-transform: uppercase;
  }
  .bsc-num {
    font-family: 'Fraunces', serif;
    font-size: 80px;
    font-weight: 700;
    color: white;
    line-height: 1;
  }
  .bsc-desc {
    margin-top: 12px;
    font-size: 13px;
    color: rgba(255,255,255,0.7);
    line-height: 1.5;
  }

  /* CPM TYPES VISUAL */
  .section-label {
    font-family: 'JetBrains Mono', monospace;
    font-size: 11px;
    letter-spacing: 3px;
    color: var(--teal);
    text-transform: uppercase;
    margin-bottom: 22px;
    padding-bottom: 10px;
    border-bottom: 1.5px solid var(--border);
    animation: fadeIn 0.6s 0.1s ease both;
  }

  .cpm-types {
    display: grid;
    grid-template-columns: repeat(3, 1fr);
    gap: 20px;
    margin-bottom: 36px;
    animation: fadeIn 0.6s 0.15s ease both;
  }
  .cpm-type-card {
    border-radius: 14px;
    overflow: hidden;
    border: 1.5px solid var(--border);
    background: white;
    box-shadow: 0 2px 12px rgba(0,0,0,0.04);
  }
  .cpm-type-header {
    padding: 14px 20px;
    font-family: 'Fraunces', serif;
    font-size: 15px;
    font-weight: 700;
    color: white;
  }
  .cpm1 .cpm-type-header { background: var(--red); }
  .cpm2 .cpm-type-header { background: var(--sage); }
  .cpm3 .cpm-type-header { background: var(--gold); }

  .cpm-type-body { padding: 20px; }

  /* Placenta diagram SVG-based */
  .placenta-viz {
    width: 100%;
    height: 90px;
    position: relative;
    margin-bottom: 14px;
  }
  .layer {
    position: absolute;
    left: 0; right: 0;
    border-radius: 8px;
    display: flex;
    align-items: center;
    justify-content: center;
  }
  .layer-cytotro {
    top: 0; height: 36px;
    font-size: 10px;
    font-family: 'JetBrains Mono', monospace;
    letter-spacing: 0.5px;
    color: rgba(255,255,255,0.85);
  }
  .layer-mesen {
    top: 46px; height: 36px;
    font-size: 10px;
    font-family: 'JetBrains Mono', monospace;
    letter-spacing: 0.5px;
  }
  /* type1: cyto abnormal, mesen normal */
  .cpm1 .layer-cytotro { background: var(--red); }
  .cpm1 .layer-mesen   { background: var(--teal-light); color: var(--teal2); }
  /* type2: cyto normal, mesen abnormal */
  .cpm2 .layer-cytotro { background: var(--teal-light); color: var(--teal2); }
  .cpm2 .layer-mesen   { background: var(--sage); color: white; }
  /* type3: both */
  .cpm3 .layer-cytotro { background: var(--red); }
  .cpm3 .layer-mesen   { background: var(--gold); color: white; }

  .cpm-tag {
    display: inline-block;
    font-family: 'JetBrains Mono', monospace;
    font-size: 9px;
    letter-spacing: 1.5px;
    padding: 4px 8px;
    border-radius: 4px;
    text-transform: uppercase;
    margin-bottom: 8px;
  }
  .cpm-tag.high-risk { background: rgba(192,57,43,0.1); color: var(--red); }
  .cpm-tag.low-risk  { background: rgba(93,139,110,0.1); color: var(--sage); }
  .cpm-tag.med-risk  { background: rgba(200,136,26,0.1); color: var(--gold); }

  .cpm-desc { font-size: 12.5px; line-height: 1.6; color: var(--ink); }
  .cpm-cfDNA-note {
    margin-top: 12px;
    padding: 8px 12px;
    border-radius: 6px;
    font-size: 11.5px;
    font-weight: 500;
  }
  .cpm1 .cpm-cfDNA-note { background: rgba(192,57,43,0.08); color: var(--red); }
  .cpm2 .cpm-cfDNA-note { background: rgba(93,139,110,0.08); color: var(--sage); }
  .cpm3 .cpm-cfDNA-note { background: rgba(200,136,26,0.08); color: var(--gold); }

  /* CPM rates comparison */
  .rates-row {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 24px;
    margin-bottom: 36px;
    animation: fadeIn 0.6s 0.25s ease both;
  }
  .rates-card {
    background: white;
    border-radius: 14px;
    padding: 28px;
    border: 1.5px solid var(--border);
  }
  .rates-card h3 {
    font-family: 'Fraunces', serif;
    font-size: 17px;
    color: var(--teal);
    margin-bottom: 18px;
  }
  .rate-item {
    display: flex;
    align-items: center;
    gap: 14px;
    margin-bottom: 14px;
  }
  .rate-name {
    font-size: 13px;
    min-width: 100px;
    color: var(--ink);
  }
  .rate-bar-bg {
    flex: 1;
    height: 18px;
    background: var(--teal-light);
    border-radius: 4px;
    overflow: hidden;
  }
  .rate-bar-fill { height: 100%; border-radius: 4px; }
  .rate-bar-fill.t21 { background: var(--sage); }
  .rate-bar-fill.t13 { background: var(--gold); }
  .rate-bar-fill.monoX { background: var(--red); }
  .rate-pct {
    font-family: 'JetBrains Mono', monospace;
    font-size: 12px;
    font-weight: 500;
    min-width: 36px;
    text-align: right;
  }

  /* Why age matters */
  .age-panel {
    background: linear-gradient(135deg, var(--teal2) 0%, #1a5e5e 100%);
    border-radius: 16px;
    padding: 36px 40px;
    color: white;
    margin-bottom: 36px;
    animation: fadeIn 0.6s 0.3s ease both;
  }
  .age-panel h3 {
    font-family: 'Fraunces', serif;
    font-size: 22px;
    margin-bottom: 22px;
    color: #e8dfc8;
  }
  .age-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 20px; }
  .age-point {
    border: 1px solid rgba(255,255,255,0.15);
    padding: 20px;
    border-radius: 10px;
    background: rgba(255,255,255,0.05);
  }
  .age-point-icon { font-size: 28px; margin-bottom: 10px; }
  .age-point-title { font-size: 13px; font-weight: 600; color: var(--gold); margin-bottom: 8px; }
  .age-point-text { font-size: 12px; color: rgba(255,255,255,0.65); line-height: 1.6; }

  /* Diagnostic implication */
  .diag-box {
    border: 2px solid var(--teal);
    border-radius: 14px;
    padding: 28px 36px;
    background: var(--teal-light);
    animation: fadeIn 0.6s 0.4s ease both;
  }
  .diag-box h3 {
    font-family: 'Fraunces', serif;
    font-size: 20px;
    color: var(--teal2);
    margin-bottom: 18px;
  }
  .diag-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 20px; }
  .diag-option {
    padding: 20px;
    border-radius: 10px;
    border: 1.5px solid;
  }
  .diag-option.no  { border-color: var(--red); background: var(--red-light); }
  .diag-option.yes { border-color: var(--teal); background: white; }
  .diag-option-label {
    font-family: 'JetBrains Mono', monospace;
    font-size: 10px;
    letter-spacing: 2px;
    text-transform: uppercase;
    margin-bottom: 8px;
  }
  .diag-option.no .diag-option-label { color: var(--red); }
  .diag-option.yes .diag-option-label { color: var(--teal); }
  .diag-option h4 { font-size: 16px; margin-bottom: 8px; }
  .diag-option p { font-size: 13px; line-height: 1.6; color: var(--muted); }

  @keyframes fadeIn {
    from { opacity:0; transform: translateY(16px); }
    to   { opacity:1; transform: translateY(0); }
  }

  @media (max-width: 900px) {
    .main, .header { padding: 24px 20px; }
    .def-row, .cpm-types, .rates-row, .age-grid, .diag-grid { grid-template-columns: 1fr; }
    .bsc-num { font-size: 56px; }
  }
</style>
</head>
<body>

<div class="header">
  <div class="eyebrow">Infografica III Â· Biologia Placentare e cfDNA</div>
  <h1>Il Confined Placental<br>Mosaicism (<em>CPM</em>)<br>come causa di Falsi Positivi</h1>
  <p class="header-sub">Il cfDNA legge la placenta, non il feto. Quando il mosaicismo Ã¨ confinato al trofoblasto, il test "vede" un'anomalia che il bambino non ha. A etÃ  avanzata, questo rischio si amplifica.</p>
  <div class="source">FONTE Â· SMFM Consult Series #74 (2025) Â· Malvestiti et al. 2015 Â· Grati et al. 2017</div>
</div>

<div class="main">

  <!-- Definition + key stat -->
  <div class="def-row">
    <div class="def-card">
      <h3>Cos'Ã¨ il Confined Placental Mosaicism?</h3>
      <p>Il CPM Ã¨ definito come la presenza di una variazione genetica rilevabile nei <strong>villi coriali</strong> (placenta) ma <strong>assente nel tessuto fetale</strong>. Origina da errori mitotici post-zigotici nelle cellule trofoblastiche precoci, dopo la separazione tra linea fetale e linea placentare. PoichÃ© il cfDNA circolante deriva quasi esclusivamente dai <strong>trofoblasti placentari</strong> (citotrofoblasto), qualsiasi mosaicismo cromosomico confinato a questo layer viene "letto" dal test come se fosse presente nel feto.</p>
      <br>
      <p>Il mosaicismo cromosomico Ã¨ presente in circa <strong>1â€“2% dei tessuti placentari</strong> analizzati ai CVS. Non Ã¨ una raritÃ .</p>
    </div>
    <div class="big-stat-card">
      <div class="bsc-label">CPM per Monosomia X (45,X)</div>
      <div class="bsc-num">59%</div>
      <div class="bsc-desc">dei casi di 45,X rilevati al NIPT hanno un CPM â€” non una vera monosomia fetale. Il piÃ¹ alto tasso di CPM tra tutti i cromosomi.</div>
    </div>
  </div>

  <!-- CPM types -->
  <div class="section-label">I tre tipi di CPM e il loro impatto sul cfDNA screening</div>
  <div class="cpm-types">
    <div class="cpm-type-card cpm1">
      <div class="cpm-type-header">CPM Tipo 1</div>
      <div class="cpm-type-body">
        <div class="placenta-viz">
          <div class="layer layer-cytotro">CITOTROFOBLASTO â€” ANOMALO (XXY)</div>
          <div class="layer layer-mesen">MESENCHIMA â€” NORMALE</div>
        </div>
        <div class="cpm-tag high-risk">âš  Alta rilevanza per cfDNA</div>
        <div class="cpm-desc">L'anomalia Ã¨ <strong>solo nel citotrofoblasto</strong>. Il feto ha cariotipo normale. Questo tipo Ã¨ il principale responsabile dei falsi positivi al NIPT per SCA.</div>
        <div class="cpm-cfDNA-note">cfDNA legge l'anomalia â†’ NIPT positivo â†’ feto sano. Falso Positivo tipico.</div>
      </div>
    </div>

    <div class="cpm-type-card cpm2">
      <div class="cpm-type-header">CPM Tipo 2</div>
      <div class="cpm-type-body">
        <div class="placenta-viz">
          <div class="layer layer-cytotro">CITOTROFOBLASTO â€” NORMALE</div>
          <div class="layer layer-mesen">MESENCHIMA â€” ANOMALO (XXY)</div>
        </div>
        <div class="cpm-tag low-risk">Meno rilevante per cfDNA</div>
        <div class="cpm-desc">L'anomalia Ã¨ <strong>solo nel mesenchima</strong>. Il cfDNA deriva dal citotrofoblasto, quindi non rileva questa anomalia placentare.</div>
        <div class="cpm-cfDNA-note">cfDNA non rileva l'anomalia â†’ NIPT negativo possibile â†’ feto con CPM non rilevato.</div>
      </div>
    </div>

    <div class="cpm-type-card cpm3">
      <div class="cpm-type-header">CPM Tipo 3</div>
      <div class="cpm-type-body">
        <div class="placenta-viz">
          <div class="layer layer-cytotro">CITOTROFOBLASTO â€” ANOMALO (XXY)</div>
          <div class="layer layer-mesen">MESENCHIMA â€” ANOMALO (XXY)</div>
        </div>
        <div class="cpm-tag med-risk">âš  Rilevante â€” alta probabilitÃ  di mosaicismo fetale</div>
        <div class="cpm-desc">L'anomalia Ã¨ <strong>in entrambi i layer</strong>. Ãˆ quello con maggiore probabilitÃ  di coinvolgere anche il feto (10â€“15% dei casi di CPM).</div>
        <div class="cpm-cfDNA-note">cfDNA positivo. Rischio concreto di vera anomalia fetale â†’ Amniocentesi obbligatoria.</div>
      </div>
    </div>
  </div>

  <!-- Rates comparison -->
  <div class="rates-row">
    <div class="rates-card">
      <h3>Tassi di CPM per cromosoma d'interesse</h3>
      <div class="rate-item">
        <span class="rate-name">Trisomia 21</span>
        <div class="rate-bar-bg"><div class="rate-bar-fill t21" style="width:2%"></div></div>
        <span class="rate-pct" style="color:var(--sage)">2%</span>
      </div>
      <div class="rate-item">
        <span class="rate-name">Trisomia 13</span>
        <div class="rate-bar-bg"><div class="rate-bar-fill t13" style="width:40%"></div></div>
        <span class="rate-pct" style="color:var(--gold)">alta</span>
      </div>
      <div class="rate-item">
        <span class="rate-name" style="font-weight:600">45,X (Turner)</span>
        <div class="rate-bar-bg"><div class="rate-bar-fill monoX" style="width:59%"></div></div>
        <span class="rate-pct" style="color:var(--red); font-weight:700">59%</span>
      </div>
      <p style="font-size:12px; color:var(--muted); margin-top:14px; line-height:1.5;">Il CPM varia enormemente per cromosoma. Le anomalie del cromosoma X hanno tassi tra i piÃ¹ alti â€” motivo per cui il PPV del NIPT per SCAs Ã¨ intrinsecamente piÃ¹ basso.</p>
    </div>

    <div class="rates-card">
      <h3>Mosaicismo fetale reale nei casi di CPM</h3>
      <div style="display:flex; align-items:center; gap:20px; margin: 18px 0;">
        <div style="text-align:center;">
          <div style="font-family:'Fraunces',serif; font-size:52px; font-weight:700; color:var(--teal); line-height:1;">10â€“15%</div>
          <div style="font-family:'JetBrains Mono',monospace; font-size:10px; color:var(--muted); text-transform:uppercase; letter-spacing:1px; margin-top:6px;">dei casi di CPM mostrano vera anomalia fetale</div>
        </div>
        <div style="flex:1;">
          <p style="font-size:13px; line-height:1.7; color:var(--ink);">Nei restanti 85â€“90% dei CPM, il feto Ã¨ cromosomicamente normale. Il <strong>CPM Tipo 1</strong> (solo citotrofoblasto) ha la minore probabilitÃ  di associarsi a mosaicismo fetale reale.</p>
        </div>
      </div>
      <div style="background:var(--red-light); border-left:3px solid var(--red); padding:12px 16px; border-radius:0 6px 6px 0; font-size:12.5px; color:var(--ink); line-height:1.6;">
        <strong>Implicazione diretta:</strong> Un NIPT positivo per XXY con CPM come causa non Ã¨ equivalente a una diagnosi fetale. Solo l'amniocentesi (non la CVS) puÃ² escluderlo definitivamente.
      </div>
    </div>
  </div>

  <!-- Why age matters -->
  <div class="age-panel">
    <h3>PerchÃ© il CPM Ã¨ piÃ¹ rilevante a 41 anni</h3>
    <div class="age-grid">
      <div class="age-point">
        <div class="age-point-icon">ðŸ§¬</div>
        <div class="age-point-title">Ovociti piÃ¹ anziani</div>
        <div class="age-point-text">Con l'avanzare dell'etÃ  materna, le cellule uovo accumulano errori meiotici. La separazione tra linea trofoblastica e linea embrionale avviene in un contesto cellulare giÃ  "compromesso" â€” aumentando il rischio di errori mitotici post-zigotici.</div>
      </div>
      <div class="age-point">
        <div class="age-point-icon">ðŸ”¬</div>
        <div class="age-point-title">InstabilitÃ  del trofoblasto</div>
        <div class="age-point-text">Le cellule trofoblastiche hanno giÃ  fisiologicamente un tasso di mosaicismo piÃ¹ alto rispetto alle cellule fetali. In presenza di una cellula uovo con maggiore instabilitÃ  cromosomica, questo fenomeno si amplifica nel CPM.</div>
      </div>
      <div class="age-point">
        <div class="age-point-icon">ðŸ“Š</div>
        <div class="age-point-title">Contesto di rischio cumulativo</div>
        <div class="age-point-text">A 41 anni la donna Ã¨ spesso sottoposta a NIPT proprio per il rischio elevato di anomalie etÃ -correlate. Ma questo crea un'aspettativa di alta probabilitÃ  pre-test che puÃ² portare a sovrastimare il significato del risultato positivo.</div>
      </div>
    </div>
  </div>

  <!-- Diagnostic implication -->
  <div class="diag-box">
    <h3>Quale test di conferma scegliere dopo NIPT+ per XXY?</h3>
    <div class="diag-grid">
      <div class="diag-option no">
        <div class="diag-option-label">âš  Non preferibile</div>
        <h4>CVS â€” Villocentesi</h4>
        <p>Campiona il tessuto placentare â€” la stessa fonte del cfDNA. Se il NIPT positivo Ã¨ causato da un CPM Tipo 1, la CVS in preparato diretto (citotrofoblasto) potrebbe "confermare" l'anomalia placentare senza rivelare nulla sul cariotipo fetale reale. Richiede spesso amniocentesi successiva.</p>
      </div>
      <div class="diag-option yes">
        <div class="diag-option-label">âœ“ Preferibile â€” SMFM 2025</div>
        <h4>Amniocentesi</h4>
        <p>Campiona il liquido amniotico â€” derivato principalmente dalle cellule fetali. Bypassa completamente la placenta e il problema del CPM. Per le SCAs con alta prevalenza di CPM (come 45,X e anomalie del cromosoma X), l'amniocentesi Ã¨ raccomandata come test di conferma di prima scelta.</p>
      </div>
    </div>
  </div>

</div>
</body>
</html>
